Woodward Diversified Capital LLC Sells 679 Shares of Danaher Co. (NYSE:DHR)

Woodward Diversified Capital LLC trimmed its position in Danaher Co. (NYSE:DHR) by 40.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,004 shares of the conglomerate’s stock after selling 679 shares during the period. Woodward Diversified Capital LLC’s holdings in Danaher were worth $230,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Fort Pitt Capital Group LLC boosted its position in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC acquired a new stake in Danaher during the 3rd quarter worth $217,000. ORG Partners LLC grew its stake in Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after acquiring an additional 2,559 shares during the period. Harvest Portfolios Group Inc. increased its holdings in shares of Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Finally, Stifel Financial Corp raised its position in shares of Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after purchasing an additional 11,216 shares during the period. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Barclays lowered their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Scotiabank began coverage on shares of Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective on the stock. UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Citigroup dropped their price target on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 price objective (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Down 1.5 %

Danaher stock opened at $206.92 on Friday. Danaher Co. has a fifty-two week low of $205.79 and a fifty-two week high of $281.70. The firm has a market capitalization of $149.45 billion, a PE ratio of 39.19, a P/E/G ratio of 2.80 and a beta of 0.83. The company’s 50-day moving average is $233.38 and its 200-day moving average is $252.10. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business earned $2.09 EPS. Sell-side analysts anticipate that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.